THE BEST SIDE OF HEMGENIX

Range of suitable patients: CDEC reviewed the uncertainty in the volume of people with reasonably critical to critical hemophilia B in Canada qualified for etranacogene dezaparvovec. Medical authorities consulted by CADTH indicated that some sufferers who're categorized as possessing mild or moderate condition might have a severe bleeding phenotype